Mast cell activation and neutrophil recruitment promotes early and robust inflammation in the meninges in EAE

Journal of Autoimmunity

Volumn 42, Issue , 2013, Pages 50-61

  Christy, Alison L ^a   Walker, Margaret E ^a   Hessner, Martin J ^b   Brown, Melissa A ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

EAE; Mast cells; Meningeal inflammation; MS; Neutrophils

Indexed keywords

TUMOR NECROSIS FACTOR;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BLOOD CEREBROSPINAL FLUID BARRIER; BLOOD VESSEL PERMEABILITY; CELL ACTIVATION; CELL INFILTRATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; IMMUNOCOMPETENT CELL; MAST CELL; MENINGITIS; MENINX; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BLOOD-BRAIN BARRIER; CELL DEGRANULATION; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; HUMANS; INFLAMMATION; MAST CELLS; MENINGES; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MULTIPLE SCLEROSIS; NEUTROPHILS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84877132598     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2012.11.003     Document Type: Article

References (98)

1. Hauser S.L., Oksenberg J.R. The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration. Neuron 2006, 52:61-76.
2. Sospedra M., Martin R. Immunology of multiple sclerosis. Annu Rev Immunol 2005, 23:683-747.
3. Ransohoff R.M., Kivisakk P., Kidd G. Three or more routes for leukocyte migration into the central nervous system. Nat Rev Immunol 2003, 3:569-581.
4. Barshes N., Demopoulos A., Engelhard H.H. Anatomy and physiology of the leptomeninges and CSF space. Cancer Treat Res 2005, 125:1-16.
5. Mack J., Squier W., Eastman J.T. Anatomy and development of the meninges: implications for subdural collections and CSF circulation. Pediatr Radiol 2009, 39:200-210.
6. Sakka L., Chazal J. The meninges, an anatomical point of view. Morphologie 2005, 89:35-42.
7. Goverman J. Autoimmune T cell responses in the central nervous system. Nat Rev Immunol 2009, 9:393-407.
8. Brown D.A., Sawchenko P.E. Time course and distribution of inflammatory and neurodegenerative events suggest structural bases for the pathogenesis of experimental autoimmune encephalomyelitis. J Comp Neurol 2007, 502:236-260.
9. Bartholomaus I., Kawakami N., Odoardi F., Schlager C., Miljkovic D., Ellwart J.W., et al. Effector T cell interactions with meningeal vascular structures in nascent autoimmune CNS lesions. Nature 2009, 462:94-98.
10. Kivisakk P., Imitola J., Rasmussen S., Elyaman W., Zhu B., Ransohoff R.M., et al. Localizing central nervous system immune surveillance: meningeal antigen-presenting cells activate T cells during experimental autoimmune encephalomyelitis. Ann Neurol 2009, 65:457-469.
11. Kivisakk P., Mahad D.J., Callahan M.K., Trebst C., Tucky B., Wei T., et al. Human cerebrospinal fluid central memory CD4+ T cells: evidence for trafficking through choroid plexus and meninges via P-selectin. Proc Natl Acad Sci U S A 2003, 100:8389-8394.
12. Kooi E.J., van Horssen J., Witte M.E., Amor S., Bo L., Dijkstra C.D., et al. Abundant extracellular myelin in the meninges of patients with multiple sclerosis. Neuropathol Appl Neurobiol 2009, 35:283-295.
13. Androdias G., Reynolds R., Chanal M., Ritleng C., Confavreux C., Nataf S. Meningeal T cells associate with diffuse axonal loss in multiple sclerosis spinal cords. Ann Neurol 2010, 68:465-476.
14. Magliozzi R., Howell O., Vora A., Serafini B., Nicholas R., Puopolo M., et al. Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain 2007, 130:1089-1104.
15. Serafini B., Rosicarelli B., Magliozzi R., Stigliano E., Aloisi F. Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis. Brain Pathol 2004, 14:164-174.
16. Lucchinetti C.F., Popescu B.F., Bunyan R.F., Moll N.M., Roemer S.F., Lassmann H., et al. Inflammatory cortical demyelination in early multiple sclerosis. N Engl J Med 2011, 365:2188-2197.
17. Magliozzi R., Columba-Cabezas S., Serafini B., Aloisi F. Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis. J Neuroimmunol 2004, 148:11-23.
18. Kuerten S., Schickel A., Kerkloh C., Recks M.S., Addicks K., Ruddle N.H., et al. Tertiary lymphoid organ development coincides with determinant spreading of the myelin-specific T cell response. Acta Neuropathol 2012, 124:861-873.
19. Columba-Cabezas S., Griguoli M., Rosicarelli B., Magliozzi R., Ria F., Serafini B., et al. Suppression of established experimental autoimmune encephalomyelitis and formation of meningeal lymphoid follicles by lymphotoxin beta receptor-Ig fusion protein. J Neuroimmunol 2006, 179:76-86.
20. Dropp J.J. Mast cells in the human brain. Acta Anat (Basel) 1979, 105:505-513.
21. Kirmi O., Sheerin F., Patel N. Imaging of the meninges and the extra-axial spaces. Semin Ultrasound CT MR 2009, 30:565-593.
22. Patel N., Kirmi O. Anatomy and imaging of the normal meninges. Semin Ultrasound CT MR 2009, 30:559-564.
23. Sayed B.A., Christy A.L., Walker M.E., Brown M.A. Meningeal mast cells affect early T cell central nervous system infiltration and blood-brain barrier integrity through TNF: a role for neutrophil recruitment?. J Immunol 2010, 184:6891-6900.
24. Marshall J.S. Mast-cell responses to pathogens. Nat Rev Immunol 2004, 4:787-799.
25. Dawicki W., Marshall J.S. New and emerging roles for mast cells in host defence. Curr Opin Immunol 2006, 19:31-38.
26. Galli S.J. The mast cell: a versatile effector cell for a challenging world. Int Arch Allergy Immunol 1997, 113:14-22.
27. Galli S.J., Kalesnikoff J., Grimbaldeston M.A., Piliponsky A.M., Williams C.M., Tsai M. Mast cells as " tunable" effector and immunoregulatory cells: recent advances. Annu Rev Immunol 2005, 23:749-786.
28. Grossmann M., Jamieson M.J., Kirch W. Histamine response and local cooling in the human skin: involvement of H1- and H2-receptors. Br J Clin Pharmacol 1999, 48:216-222.
29. Kunder C.A., St John A.L., Abraham S.N. Mast cell modulation of the vascular and lymphatic endothelium. Blood 2011, 118:5383-5393.
30. Secor V.H., Secor W.E., Gutekunst C.A., Brown M.A. Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis. J Exp Med 2000, 191:813-822.
31. Carlson T., Kroenke M., Rao P., Lane T.E., Segal B. The Th17-ELR+ CXC chemokine pathway is essential for the development of central nervous system autoimmune disease. J Exp Med 2008, 205:811-823.
32. Ohtsu H., Tanaka S., Terui T., Hori Y., Makabe-Kobayashi Y., Pejler G., et al. Mice lacking histidine decarboxylase exhibit abnormal mast cells. FEBS Lett 2001, 502:53-56.
33. Gentleman R.C., Carey V.J., Bates D.M., Bolstad B., Dettling M., Dudoit S., et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 2004, 5:R80.
34. Hong F., Breitling R., McEntee C.W., Wittner B.S., Nemhauser J.L., Chory J. RankProd: a bioconductor package for detecting differentially expressed genes in meta-analysis. Bioinformatics 2006, 22:2825-2827.
35. Sturn A., Quackenbush J., Trajanoski Z. Genesis: cluster analysis of microarray data. Bioinformatics 2002, 18:207-208.
36. Edgar R., Domrachev M., Lash A.E. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 2002, 30:207-210.
37. Huang D.W., Sherman B.T., Lempicki R.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009, 4:44-57.
38. Huang D.W., Sherman B.T., Lempciki R.A. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 2009, 37:1-13.
39. Lindsberg P.J., Strbian D., Karjalainen-Lindsberg M.L. Mast cells as early responders in the regulation of acute blood-brain barrier changes after cerebral ischemia and hemorrhage. J Cereb Blood Flow Metab 2010, 30:689-702.
40. Theoharides T.C., Konstantinidou A.D. Corticotropin-releasing hormone and the blood-brain-barrier. Front Biosci 2007, 12:1615-1628.
41. Zhuang X., Silverman A.J., Silver R. Brain mast cell degranulation regulates blood-brain barrier. J Neurobiol 1996, 31:393-403.
42. Huang M., Berry J., Kandere K., Lytinas M., Karalis K., Theoharides T.C. Mast cell deficient W/W(v) mice lack stress-induced increase in serum IL-6 levels, as well as in peripheral CRH and vascular permeability, a model of rheumatoid arthritis. Int J Immunopathol Pharmacol 2002, 15:249-254.
43. Ramos B.F., Zhang Y., Angkachatchai V., Jakschik B.A. Mast cell mediators regulate vascular permeability changes in Arthus reaction. J Pharmacol Exp Ther 1992, 262:559-565.
44. Singh L.K., Boucher W., Pang X., Letourneau R., Seretakis D., Green M., et al. Potent mast cell degranulation and vascular permeability triggered by urocortin through activation of corticotropin-releasing hormone receptors. J Pharmacol Exp Ther 1999, 288:1349-1356.
45. Theoharides T.C., Singh L.K., Boucher W., Pang X., Letourneau R., Webster E., et al. Corticotropin-releasing hormone induces skin mast cell degranulation and increased vascular permeability, a possible explanation for its proinflammatory effects. Endocrinology 1998, 139:403-413.
46. Theoharides T.C., Kalogeromitros D. The critical role of mast cells in allergy and inflammation. Ann N Y Acad Sci 2006, 1088:78-99.
47. Ramos B.F., Zhang Y., Qureshi R., Jakschik B.A. Mast cells are critical for the production of leukotrienes responsible for neutrophil recruitment in immune complex-induced peritonitis in mice. J Immunol 1991, 147:1636-1641.
48. Zhang Y., Ramos B.F., Jakschik B.A. Neutrophil recruitment by tumor necrosis factor from mast cells in immune complex peritonitis. Science 1992, 258:1957-1959.
49. Ramos B.F., Zhang Y., Jakschik B.A. Neutrophil elicitation in the reverse passive Arthus reaction. Complement-dependent and -independent mast cell involvement. J Immunol 1994, 152:1380-1384.
50. Zhang Y., Ramos B.F., Jakschik B., Baganoff M.P., Deppeler C.L., Meyer D.M., et al. Interleukin 8 and mast cell-generated tumor necrosis factor-alpha in neutrophil recruitment. Inflammation 1995, 19:119-132.
51. Mercer-Jones M.A., Shrotri M.S., Heinzelmann M., Peyton J.C., Cheadle W.G. Regulation of early peritoneal neutrophil migration by macrophage inflammatory protein-2 and mast cells in experimental peritonitis. J Leukoc Biol 1999, 65:249-255.
52. Biedermann T., Kneilling M., Mailhammer R., Maier K., Sander C.A., Kollias G., et al. Mast cells control neutrophil recruitment during T cell-mediated delayed-type hypersensitivity reactions through tumor necrosis factor and macrophage inflammatory protein 2. J Exp Med 2000, 192:1441-1452.
53. Chen R., Ning G., Zhao M.L., Fleming M.G., Diaz L.A., Werb Z., et al. Mast cells play a key role in neutrophil recruitment in experimental bullous pemphigoid. J Clin Invest 2001, 108:1151-1158.
54. Wang Y., Thorlacius H. Mast cell-derived tumour necrosis factor-alpha mediates macrophage inflammatory protein-2-induced recruitment of neutrophils in mice. Br J Pharmacol 2005, 145:1062-1068.
55. Strbian D., Karjalainen-Lindsberg M.L., Tatlisumak T., Lindsberg P.J. Cerebral mast cells regulate early ischemic brain swelling and neutrophil accumulation. J Cereb Blood Flow Metab 2006, 26:605-612.
56. Echtenacher B., Mannel D.N., Hultner L. Critical protective role of mast cells in a model of acute septic peritonitis. Nature 1996, 381:75-77.
57. Malaviya R., Ikeda T., Ross E., Abraham S. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-alpha. Nature 1996, 381:77-80.
58. Brown A., McFarlin D.E., Raine C.S. Chronologic neuropathology of relapsing experimental allergic encephalomyelitis in the mouse. Lab Invest 1982, 46:171-185.
59. Blanchet M.R., Gold M., Maltby S., Bennett J., Petri B., Kubes P., et al. Loss of CD34 leads to exacerbated autoimmune arthritis through increased vascular permeability. J Immunol 2010, 184:1292-1299.
60. Carvalho R.F., Ribeiro R.A., Falcao R.A., Lima R.C., Leitao R.F., Alcantara C., et al. Angiotensin II potentiates inflammatory edema in rats: role of mast cell degranulation. Eur J Pharmacol 2006, 540:175-182.
61. DiStasi M.R., Ley K. Opening the flood-gates: how neutrophil-endothelial interactions regulate permeability. Trends Immunol 2009, 30:547-556.
62. Lindbom L. Regulation of vascular permeability by neutrophils in acute inflammation. Chem Immunol Allergy 2003, 83:146-166.
63. Scholz M., Cinatl J., Schadel-Hopfner M., Windolf J. Neutrophils and the blood-brain barrier dysfunction after trauma. Med Res Rev 2007, 27:401-416.
64. Bolton S.J., Anthony D.C., Perry V.H. Loss of the tight junction proteins occludin and zonula occludens-1 from cerebral vascular endothelium during neutrophil-induced blood-brain barrier breakdown in vivo. Neuroscience 1998, 86:1245-1257.
65. Perry V.H., Anthony D.C., Bolton S.J., Brown H.C. The blood-brain barrier and the inflammatory response. Mol Med Today 1997, 3:335-341.
66. Anthony D.C., Bolton S.J., Fearn S., Perry V.H. Age-related effects of interleukin-1 beta on polymorphonuclear neutrophil-dependent increases in blood-brain barrier permeability in rats. Brain 1997, 120(Pt 3):435-444.
67. Ransohoff R.M., Brown M.A. Innate immunity in the central nervous system. J Clin Invest 2012, 122:1164-1171.
68. Bolton S.J., Perry V.H. Differential blood-brain barrier breakdown and leucocyte recruitment following excitotoxic lesions in juvenile and adult rats. Exp Neurol 1998, 154:231-240.
69. Butt A.M., Jones H.C. Effect of histamine and antagonists on electrical resistance across the blood-brain barrier in rat brain-surface microvessels. Brain Res 1992, 569:100-105.
70. Lawrenson J.G., Reid A.R., Allt G. Molecular characteristics of pial microvessels of the rat optic nerve. Can pial microvessels be used as a model for the blood-brain barrier?. Cell Tissue Res 1997, 288:259-265.
71. Nagy Z., Peters H., Huttner I. Fracture faces of cell junctions in cerebral endothelium during normal and hyperosmotic conditions. Lab Invest 1984, 50:313-322.
72. Popescu B.F., Lucchinetti C.F. Meningeal and cortical grey matter pathology in multiple sclerosis. BMC Neurol 2012, 12:11.
73. Magliozzi R., Howell O.W., Reeves C., Roncaroli F., Nicholas R., Serafini B., et al. A gradient of neuronal loss and meningeal inflammation in multiple sclerosis. Ann Neurol 2010, 68:477-493.
74. Cassatella M.A. Neutrophil-derived proteins: selling cytokines by the pound. Adv Immunol 1999, 73:369-509.
75. Scapini P., Lapinet-Vera J.A., Gasperini S., Calzetti F., Bazzoni F., Cassatella M.A. The neutrophil as a cellular source of chemokines. Immunol Rev 2000, 177:195-203.
76. Pelletier M., Micheletti A., Cassatella M.A. Modulation of human neutrophil survival and antigen expression by activated CD4+ and CD8+ T cells. J Leukoc Biol 2010, 88:1163-1170.
77. Pelletier M., Maggi L., Micheletti A., Lazzeri E., Tamassia N., Costantini C., et al. Evidence for a cross-talk between human neutrophils and Th17 cells. Blood 2010, 115:335-343.
78. Mantovani A., Cassatella M.A., Costantini C., Jaillon S. Neutrophils in the activation and regulation of innate and adaptive immunity. Nat Rev Immunol 2011, 11:519-531.
79. Nakae S., Suto H., Berry G.J., Galli S.J. Mast cell-derived TNF can promote Th17 cell-dependent neutrophil recruitment in ovalbumin-challenged OTII mice. Blood 2007, 109:3640-3648.
80. Ott V.L., Cambier J.C., Kappler J., Marrack P., Swanson B.J. Mast cell-dependent migration of effector CD8+ T cells through production of leukotriene B4. Nat Immunol 2003, 4:974-981.
81. Nakae S., Suto H., Iikura M., Kakurai M., Sedgwick J.D., Tsai M., et al. Mast cells enhance T cell activation: importance of mast cell costimulatory molecules and secreted TNF. J Immunol 2006, 176:2238-2248.
82. Nakae S., Suto H., Kakurai M., Sedgwick J.D., Tsai M., Galli S.J. Mast cells enhance T cell activation: importance of mast cell-derived TNF. Proc Natl Acad Sci U S A 2005, 102:6467-6472.
83. Baram D., Vaday G.G., Salamon P., Drucker I., Hershkoviz R., Mekori Y.A. Human mast cells release metalloproteinase-9 on contact with activated T cells: juxtacrine regulation by TNF-alpha. J Immunol 2001, 167:4008-4016.
84. Salamon P., Shoham N.G., Gavrieli R., Wolach B., Mekori Y.A. Human mast cells release interleukin-8 and induce neutrophil chemotaxis on contact with activated T cells. Allergy 2005, 60:1316-1319.
85. Salamon P., Shoham N.G., Puxeddu I., Paitan Y., Levi-Schaffer F., Mekori Y.A. Human mast cells release oncostatin M on contact with activated T cells: possible biologic relevance. J Allergy Clin Immunol 2008, 121:448-455. e5.
86. Derecki N.C., Cardani A.N., Yang C.H., Quinnies K.M., Crihfield A., Lynch K.R., et al. Regulation of learning and memory by meningeal immunity: a key role for IL-4. J Exp Med 2010, 207:1067-1080.
87. Holman D.W., Klein R.S., Ransohoff R.M. The blood-brain barrier, chemokines and multiple sclerosis. Biochim Biophys Acta 2011, 1812:220-230.
88. Katz H.R., Austen K.F. Mast cell deficiency, a game of kit and mouse. Immunity 2011, 35:668-670.
89. Brown M.A., Hatfield J.K., Walker M.E., Sayed B.A. A game of kit and mouse: the kit is still in the bag. Immunity 2012, 36:891-892.
90. Piconese S., Costanza M., Musio S., Tripodo C., Poliani P.L., Gri G., et al. Exacerbated experimental autoimmune encephalomyelitis in mast-cell-deficient kit W-sh/W-sh mice. Lab Invest 2011, 91:627-641.
91. Stelekati E., Bahri R., D'Orlando O., Orinska Z., Mittrucker H.W., Langenhaun R., et al. Mast cell-mediated antigen presentation regulates CD8+ T cell effector functions. Immunity 2009, 31:665-676.
92. Bennett J.L., Blanchet M.R., Zhao L., Zbytnuik L., Antignano F., Gold M., et al. Bone marrow-derived mast cells accumulate in the central nervous system during inflammation but are dispensable for experimental autoimmune encephalomyelitis pathogenesis. J Immunol 2009, 182:5507-5514.
93. Li H., Nourbakhsh B., Safavi F., Li K., Xu H., Cullimore M., et al. Kit (W-sh) mice develop earlier and more severe experimental autoimmune encephalomyelitis due to absence of immune suppression. J Immunol 2011, 187:274-282.
94. Feyerabend T.B., Weiser A., Tietz A., Stassen M., Harris N., Kopf M., et al. Cre-mediated cell ablation contests mast cell contribution in models of antibody- and T cell-mediated autoimmunity. Immunity 2011, 35:832-844.
95. Rao K.N., Brown M.A. Mast cells: multifaceted immune cells with diverse roles in health and disease. Ann N Y Acad Sci 2008, 1143:83-104.
96. Medic N., Vita F., Abbate R., Soranzo M.R., Pacor S., Fabbretti E., et al. Mast cell activation by myelin through scavenger receptor. J Neuroimmunol 2008, 200:27-40.
97. Collington S.J., Williams T.J., Weller C.L. Mechanisms underlying the localisation of mast cells in tissues. Trends Immunol 2011, 32:478-485.
98. Hallgren J., Gurish M.F. Mast cell progenitor trafficking and maturation. Adv Exp Med Biol 2011, 716:14-28.